Marinomed Biotech AG logo

MARI - Marinomed Biotech AG News Story

€125 -3.0  -2.3%

Last Trade - 4:35pm

Sector
Healthcare
Size
Small Cap
Market Cap £163.0m
Enterprise Value £166.1m
Revenue £7.02m
Position in Universe 656th / 1049

BRIEF-Marinomed Biotech FY Revenues Up At EUR 8.1 Mln

Wed 14th April, 2021 6:51am
April 14 (Reuters) - MARINOMED BIOTECH AG  MARI.VI :
    * FY REVENUES OF EUR 8.1 M, AN INCREASE OF 32% (2019: EUR
6.1 M)
    * FY RESEARCH AND DEVELOPMENT SPENDING OF EUR 5.9 M IN 2020,
UP
24% FROM EUR 4.8 M IN 2019
    * FY REDUCED LOSS OF EUR 6.0 M (2019: EUR 7.2 M)
    * FY MEETS FINANCIAL OUTLOOK FOR 2020
    * EXPECTS A SLIGHT INCREASE IN RESEARCH AND  DEVELOPMENT
COSTS
LEADING TO AN OPERATING LOSS IN 2021

Further company coverage:  MARI.VI 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.